Results
Looking back at the TechTransfer Talk: Bridging Research & Business
On March 4, 2025, VUB TechTransfer hosted the TechTransfer Talk: Bridging Research & Business, exploring the business developer’s role in connecting applied research with the business world.
Read more
FLEXMCS
The ERIS team proudly announces that the FLEXMCS consortium has received an EU grant. Prof. Omar Hegazy, member of MOBI VUB and head of EPOWERS Research Group, will coordinate this consortium.
Read more
Advancing liver research for better therapies and safer chemicals
What if liver diseases and liver toxicity could be detected, prevented and treated more effectively, without relying on outdated testing models? B-Liver transforms the way liver biology is studied, toxicity is assessed, and new therapies are developed.
Read more
Innovative imaging for optimal, personalised breast cancer treatment
What if a single scan could reveal a more complete picture of a patient's cancer? VUB spin-off ABSCINT is using innovative single-domain antibodies, enabling clinicians to visualise tumours throughout the entire body, helping deliver faster, more precise, and truly personalised treatment.
Read more
In the picture
Read more
Home
Read more
Get to know Alessandra Rossetti
Meet Alessandra, our business developer in the ERIS team.
Read more
HEALANT secures €4 million to bring self-healing tire technology to market
VUB start-up HEALANT has secured €4M in a funding round co-led by Radix Ventures and Entrevest to commercialise its self-healing tire technology.
Read more